During the eight years to 320 million allocated to boost development in biological drugs.

”There is a great potential”, according to Vinnova that hold in the betting.

A company wants to develop the magnetic separation to purify the antibodies.

A university is to go ahead with a treatment of multi-drug resistant bacteria.

There are two of eleven projects were selected out of 40 who were looking for when Vinnova and the Swedish research council made a public announcement about the biological drugs last year.

The next few years there will be new rounds.

The text above is a summary, you can read full article here.